我要投票 英华融泰YHRT MEDICAL在保险行业中的票数:301
· 外 推 电 报 ·
2025-06-29 18:55:31 星期日

【英华融泰YHRT MEDICAL是哪个国家的品牌?】

英华融泰YHRT MEDICAL是什么牌子?「英华融泰YHRT MEDICAL」是 英华融泰医疗科技股份有限公司 旗下著名品牌。该品牌发源于内蒙古包头市,由创始人牛毅在2004-07-05期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力英华融泰YHRT MEDICAL品牌出海!将品牌入驻外推网,定制英华融泰YHRT MEDICAL品牌推广信息,可以显著提高英华融泰YHRT MEDICAL产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

国内知名雾化器品牌,专业从事雾化器及呼吸系统医用耗材的研发、生产、销售的大型企业


英华融泰医疗科技股份有限公司由海外留学人员于2004年领办创立,专业从事雾化器及呼吸系统医用耗材的研发、生产、销售,目前有18个系列近280种产品面向全国销售,覆盖了4000余家医院和上百万家庭。

公司技术力量雄厚,专业从事器械研发人员26人,研发设备先进,与各大院校和医院等研发机构建立了良好的战略合作关系,目前已经获得国家专利34项,产品受到医院和家庭的欢迎,得到业内专家高度认可和大力推崇。

公司产品覆盖全国各地,与经销商和终端用户建立了良好的合作关系,多年来不断为患者提供产品,为解除患者病痛做出贡献。公司生产设备先进,设施完备,产品质量稳定,已经成为一面旗帜带领着中国雾化器市场的发展方向。

公司通过了国家高新技术企业认证、获得了科技型中小企业创新基金、成为了包头市专利试点保护企业、获得了科技进步奖的奖励、得到了内蒙古特色中小企业基金的扶持、被市政府评为专利工作先进集体、得到了国务院侨办重点华人华侨项目的支持。

英华融泰秉承“以人为本,科技创新,服务医患,强企报国”的理念,以自身与各大医院的密切联系愿意与各医疗器械生产、经营公司共同分享从事医疗器械生产销售所带来的乐趣,实现双赢;英华融泰愿意与一切致力于医学研究的所有专家学者共同合作开创医疗器械行业的美好未来,共享繁荣。


英文翻译:Yinghua Rongtai Medical Technology Co., Ltd., a famous domestic atomizer brand, is a large-scale enterprise specializing in the research, development, production and sales of atomizers and respiratory system medical consumables. It was founded in 2004 by overseas students. It specializes in the research, development, production and sales of atomizers and respiratory system medical consumables. At present, there are 18 series of nearly 280 products sold nationwide, covering More than 4000 hospitals and millions of families. The company has strong technical force, 26 professional equipment R & D personnel and advanced R & D equipment. It has established a good strategic cooperation relationship with various universities and hospitals and other R & D institutions. At present, it has obtained 34 national patents, and its products are welcomed by hospitals and families, highly recognized and highly praised by experts in the industry. The company's products cover all over the country, and has established a good cooperation relationship with dealers and end users. Over the years, it has been providing products for patients and contributing to the relief of patients' pain. The company has advanced production equipment, complete facilities and stable product quality, which has become a banner leading the development direction of China's atomizer market. The company has passed the national high and new technology enterprise certification, won the Innovation Fund for small and medium-sized scientific and technological enterprises, became a pilot patent protection enterprise in Baotou City, won the award of science and technology progress award, obtained the support of the fund for small and medium-sized enterprises with Inner Mongolia characteristics, was rated as the advanced group of patent work by the municipal government, and obtained the support of key overseas Chinese projects of overseas Chinese office of the State Council. Yinghua Rongtai adheres to the concept of "people-oriented, scientific and technological innovation, serving doctors and patients, strengthening enterprises and serving the country", and is willing to share the fun of engaging in the production and sales of medical devices with all medical device production and operation companies with its close contact with major hospitals to achieve a win-win situation; Yinghua Rongtai is willing to cooperate with all experts and scholars who are committed to medical research to create medical treatment The bright future of the equipment industry, sharing prosperity.

本文链接: https://www.waitui.com/brand/0e3e37551.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

成都先导:终止收购南京海纳医药科技约65%股权事项

成都先导公告,公司原拟以现金方式受让股权的方式合计取得南京海纳医药科技股份有限公司约65%的股权。《股权收购意向书》签署后,公司积极组织交易各方推进本次交易,聘请了专业的中介机构对标的公司展开尽调,在此基础上,交易各方对本次交易方案进行多次论证和协商,但未能就本次交易事项的核心条款达成一致意见。 为切实维护公司及全体股东利益,经公司充分审慎研究并与交易对方友好协商,交易各方一致同意终止本次交易事项,本次重大资产重组事项终止。

56分钟前

磁谷科技股东宝利丰拟减持,不超过总股本3%

6月29日,磁谷科技公告显示,股东南京宝利丰创业投资合伙企业(有限合伙)因自身资金安排,拟通过集中竞价、大宗交易的方式减持其持有的公司股份不超过2,149,569股。减持不超过公司总股本的3.00%。

56分钟前

中信证券:中报季还是以结构性机会为主,预计AI和军工是三季度寻找结构性机会的重心

近日,中信证券研报指出,从板块轮动来看,活跃资金或正从医药和消费切向科技和金融,红利也开始滞涨。结构性机会仍料将是贯穿中报季的话题,指数型机会可能还需要等三季度末到四季度。预计AI和军工是三季度寻找结构性机会的重心。(财联社)

56分钟前

*ST金刚:孙公司金刚数智签订3.99亿元重大算力销售合同

6月29日,*ST金刚发布公告称,公司下属孙公司北京金刚数海智算科技有限公司(简称“金刚数智”)于2025年6月27日与江苏***大数据有限公司(简称“算力客户”)签订了《智算中心多元算力服务项目之服务协议》。由金刚数智向算力客户提供算力服务,合同含税总金额3.99亿元,服务期限5年,按月度支付算力服务费用。

56分钟前

紫光国微:6月27日以4961.73万元回购77.55万股公司股份

6月29日,紫光国微发布公告称,6月27日公司通过股份回购专用证券账户以集中竞价交易方式实施了首次回购(以下简称“本次回购”)。回购公司股份数量77.55万股,约占公司目前总股本的0.09%,最高成交价为64.28元/股,最低成交价为63.67元/股,成交金额为4961.73万元(不含交易费用)。本次回购资金来源为公司自有资金,回购价格未超过前述回购公司股份方案的规定。

56分钟前

本页详细列出关于英华融泰YHRT MEDICAL的品牌信息,含品牌所属公司介绍,英华融泰YHRT MEDICAL所处行业的品牌地位及优势。
咨询